Majestic poplar

Podcast: Play in new window | Download
Newsletter #32 covers – School and the Covid Generation
Newsletter #34 covers – Long Covid and its association with Epstein Barr Virus, EBV, reactivation

Majestic poplar

Podcast: Play in new window | Download
Newsletter #32 covers – School and the Covid Generation
Newsletter #34 covers – Long Covid and its association with Epstein Barr Virus, EBV, reactivation


Podcast: Play in new window | Download
Dr. Danny Benjamin joins me today to discuss COVID19 in children, vaccines and the critical research that his team performed regarding back to school in North Carolina. He is the Kiser Arena Distinguished Professor of Pediatrics at Duke University and the Principle Investigator of the National Institute of Child Health and Human Development Pediatric Trials Network. His group performed two large trials of children going back to school in 2020 effectively proving that children being in school face to face was and is safe. We discuss the safety of the mRNA vaccines in the 12 year old and older age group. We dive deep into the risks and fallout from natural COVID infections as well as weigh the scales of vaccination versus natural disease in older children. He is a wealth of knowledge and I am grateful for his time.
Enjoy my conversation with Dr. Danny Benjamin,
Dr. M


Podcast: Play in new window | Download


Podcast: Play in new window | Download

Podcast: Play in new window | Download
What are the latest data trends with COVID and children? What vaccine related issues have arisen? We answer these questions and more!
Quick hits
1) Sequelae following a moderate to severe COVID infection continue to plague medical systems. In a new study in the British Medical Journal, we see a 14% increased risk of developing new onset clinical conditions.
“14% of adults aged ≤65 who were infected with SARS-CoV-2 (27 074 of 193 113) had at least one new type of clinical sequelae that required medical care after the acute phase of the illness, which was 4.95% higher than in the 2020 comparator group. The risk for specific new sequelae attributable to SARS-Cov-2 infection after the acute phase, including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety, and fatigue, was significantly greater than in the three comparator groups (2020, 2019, and viral lower respiratory tract illness groups).” (Daugherty et. al. 2021)……….
Read More: Link
Enjoy,
Dr. M


Podcast: Play in new window | Download